Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Baclofen for Dysautonomia and Hypertonia in Severe Brain Injury
NCT00221689Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of baclofen in dysautonomia, hypertension (HTN), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Mar 2003; status: terminated.
02
Drugs
baclofen
03
Conditions
dysautonomiahypertension (HTN)
Beyond the preview
Go deeper on NCT00221689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221689.